Reducing sitting time for Black adults with chronic kidney disease
An Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease: RESET-CKD
NA · University of Illinois at Chicago · NCT06754280
This study tests if helping Black adults with chronic kidney disease sit less and be more active can improve their health over 12 weeks.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 40 (estimated) |
| Ages | 35 Years to 80 Years |
| Sex | All |
| Sponsor | University of Illinois at Chicago (other) |
| Locations | 1 site (Chicago, Illinois) |
| Trial ID | NCT06754280 on ClinicalTrials.gov |
What this trial studies
RESET-CKD is designed to help Black adults aged 35 to 80 with chronic kidney disease (CKD) reduce their sedentary behavior. Participants will be randomly assigned to either an intervention group focused on decreasing sitting time or a control group receiving CKD-related education. The study will follow participants for 12 weeks to assess the effectiveness of the intervention in promoting more active lifestyles. The goal is to improve health outcomes by addressing sedentary behavior in this population.
Who should consider this trial
Good fit: Ideal candidates are Black or African American adults aged 35 to 80 with CKD stages 1-4 who report 6 or more hours of sedentary time daily.
Not a fit: Patients who are unable to walk a block or have conditions that severely limit mobility may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could lead to improved health outcomes and quality of life for Black adults with chronic kidney disease by reducing sedentary behavior.
How similar studies have performed: While there is ongoing research into sedentary behavior interventions, this specific approach targeting Black adults with CKD is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Self-identifies as Black or African American * Age ≥35 to ≤80 years old * CKD Stage 1-4 * Self-reported 6 or more hours/day of sedentary time * Ability to speak/read/understand English * Has access to a telephone Exclusion Criteria: * Being unable to walk 1 block * Being unable to stand from a seated position without assistance * Using a wheelchair, walker, or cane for all of their ambulation * Presence of a condition(s) or diagnosis, either physical or psychological, that precludes participation, including: Lower-extremity amputation (AKA or BKA) without prosthetic, Orthopedic condition that would preclude prompted sit-to-stand transitions or standing, Neurologic or psychiatric condition that would preclude prompted sit-to- stand transitions or standing, Severe cognitive impairment, Unstable coronary artery disease (i.e., angina with activity), Orthostatic hypotension * Kidney transplant * Any other condition that the investigator considers precludes participation in the trial * Participated in the Patient Advisory Board
Where this trial is running
Chicago, Illinois
- UI Health/University of Illinois Chicago — Chicago, Illinois, United States (RECRUITING)
Study contacts
- Study coordinator: Mary Hannan, PhD
- Email: mhanna22@uic.edu
- Phone: 3123554838
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Chronic Kidney Disease, Sedentary